Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Respiratory Tract Infections
Open-data reference.
16 US clinical trials · 4 currently recruiting
Active & Recent Trials
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
University of Nebraska
NCT05864118
Beetroot Juice NO Cold Study
Southern Methodist University
NCT06416228
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
The University of Texas Health Science Center, Houston
NCT06070688
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Geisinger Clinic
NCT06495021
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
Restorbio
NCT03373903
Patient Portal Flu Vaccine Reminders (RCT 6)
University of California, Los Angeles
NCT06062264
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults
Medicago
NCT03301051
Home Testing of Respiratory Illness
Evidation Health
NCT04245800
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
The Cooper Health System
NCT04596657
Audio Data Collection for Identification and Classification of Coughing
HealthMode
NCT04326309
Hand Hygiene Randomized Cluster Intervention to Reduce Infections
Kent State University
NCT02131727
Rapid Detection of Airway Pathogens for Lung Transplantation
University of California, San Francis
NCT03933878
Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)
Georgetown University
NCT00481507
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
Penn State University
NCT00127686
A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age
Janssen Vaccines & Prevention B.V.
NCT03303625
A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness
Duke University
NCT03741322
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Respiratory Tract Infections Trial Landscape
ClinicalTrials.gov lists 16 US studies indexed under Respiratory Tract Infections, and 4 of those are currently open to recruitment — roughly 25% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Respiratory Tract Infections shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 4 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Respiratory Tract Infections is led by HealthMode with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 16 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Respiratory Tract Infections?
PlainTrial tracks 16 US clinical trials for Respiratory Tract Infections, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Respiratory Tract Infections?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.